Paper7302889
Antithrombin III, the major modulator of intravascular coagulation, is synthesized by human endothelial cells.
Chan TK and 1 other. Thromb Haemost, 1981. Cited by 68 papers, by iCite.
Cite this record
ConductScience Library. Antithrombin III, the major modulator of intravascular coagulation, is synthesized by human endothelial cells. Papers, record 7302889. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7302889
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Antithrombin III, the major modulator of intravascular coagulation, is synthesized by human endothelial cells.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antithrombin III | Major topic |
| Blood Vessels | Major topic |
| Autoradiography | |
| Cells, Cultured | |
| Endothelium | |
| Factor X | |
| Factor Xa | |
| Heparin | |
| Humans | |
| Immunoelectrophoresis, Two-Dimensional | |
| Neutralization Tests | |
| Thrombin |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34324733 | Cullin 2-RBX1 E3 ligase and USP2 regulate antithrombin ubiquitination and stability. | FASEB J | 2021 | https://conductscience.org/library/papers/34324733 | PubMed |
| 31242030 | Endothelial PAI-1 (Plasminogen Activator Inhibitor-1) Blocks the Intrinsic Pathway of Coagulation, Inducing the Clearance and Degradation of FXIa (Activated Factor XI). | Arterioscler Thromb Vasc Biol | 2019 | https://conductscience.org/library/papers/31242030 | PubMed |
| 30319401 | Dexamethasone Preconditioning in Cardiac Procedures Reduces Decreased Antithrombin Activity and Is Associated to Beneficial Outcomes: Role of Endothelium. | Front Pharmacol | 2018 | https://conductscience.org/library/papers/30319401 | PubMed |
| 22427833 | A novel serpin with antithrombin-like activity in Branchiostoma japonicum: implications for the presence of a primitive coagulation system. | PLoS One | 2012 | https://conductscience.org/library/papers/22427833 | PubMed |
| 12055127 | Enzymatic activation of endothelial protease-activated receptors is dependent on artery diameter in human and porcine isolated coronary arteries. | Br J Pharmacol | 2002 | https://conductscience.org/library/papers/12055127 | PubMed |
| 6425214 | Rickettsial interactions with human endothelial cells in vitro: adherence and entry. | Infect Immun | 1984 | https://conductscience.org/library/papers/6425214 | PubMed |
| 6425064 | Deficiency of antithrombin III in children with hemolytic-uremic syndrome. | Eur J Pediatr | 1984 | https://conductscience.org/library/papers/6425064 | PubMed |
| 3308602 | Endothelial cell function in diabetic microangiopathy. | Diabetologia | 1987 | https://conductscience.org/library/papers/3308602 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| F2 | 2147 | PubTator's text mining | https://conductscience.org/library/genes/2147 | NCBI Gene |
| SERPINC1 | 462 | PubTator's text mining | https://conductscience.org/library/genes/462 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7302889
GET https://conductscience.org/api/papers/v1/7302889/authors